The increased expression of adhesion molecules ICAM‐3, E‐ and P‐selectins on breast cancer endothelium
- 1 December 1995
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 177 (4) , 369-376
- https://doi.org/10.1002/path.1711770407
Abstract
Sequential interaction of neoplastic cells with the endothelium of tumour neovasculature is believed to be a significant step in tumour metastasis. Increasing evidence suggests that inducible endothelial adhesion molecules are intimately involved in this process. An immunohistochemical approach was used to examine the expression of adhesion molecules in 14 normal controls and a series of 64 invasive breast carcinomas. Endothelium in normal breast showed constitutive expression of PECAM (100 per cent), ICAM‐2 (100 per cent), and P‐selectin (64 per cent); variable and focal expression of ICAM‐1 (71 per cent); and only weak staining for E‐selectin (21 per cent). No ICAM‐3 or VCAM‐1 expression was observed. Similarly to normal breast endothelium, widespread and intense immunoreactivity on the endothelium of tumour‐associated vessels was seen for PECAM (100 per cent), ICAM‐1 (69 per cent), and ICAM‐2 (95 per cent). In contrast to normal tissues, E‐ and P‐selectins showed increased intensity of staining (52 and 67 per cent of cases, respectively) and expression of E‐ and P‐selectins was more prominent at the tumour periphery. ICAM‐3 expression was increased on tumour endothelium (15 per cent of cases), but in common with VCAM‐1 (10 per cent) expression was focal. A previously unreported finding was the immunoreactivity of the neoplastic epithelial cells for the non‐epithelial lineage markers ICAM‐1 (34 per cent), ICAM‐3 (10·9 per cent), PECAM (1·6 per cent), and E‐ and P‐selectins (7 and 37 per cent of cases, respectively). These findings show that tumour endothelium displays significant heterogeneity and can assume a pro‐inflammatory phenotype, probably as a result of cytokine stimulation. Upregulation of adhesion molecules might contribute to changes in invasive phenotype by promoting endothelial cell adhesion and angiogenesis, as well as forming a substratum for tumour cells to assemble and attract macrophages.Keywords
This publication has 27 references indexed in Scilit:
- Cell Adhesion Molecule Expression within the Microvasculature of Human Colorectal MalignanciesClinical Immunology and Immunopathology, 1994
- A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesisNature, 1993
- Lymphocyte-Endothelial Cell Adhesion Molecules at the Primary Tumor Site in Human Lung and Renal Cell CarcinomasJNCI Journal of the National Cancer Institute, 1993
- Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodiesVirchows Archiv B Cell Pathology Including Molecular Pathology, 1992
- Biology of tumour metastasisThe Lancet, 1992
- Functional characterization of tumor‐infiltrating lymphocytes, lymph‐node lymphocytes and peripheral‐blood lymphocytes from patients with breast cancerInternational Journal of Cancer, 1991
- Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.The Journal of Experimental Medicine, 1991
- Novel growth regulatory factors and tumour angiogenesisEuropean Journal of Cancer and Clinical Oncology, 1991
- Tumor interactions with the vasculature: angiogenesis and tumor metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990